Presentation TCT 2018 Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement? Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber September 23, 2018
Presentation TCT 2018 Who Is the High Bleeding Risk Patient, and How Should DAPT Duration Be Weighed Against Ischemic Risk? Presenter: Deepak L. Bhatt, Tullio Palmerini, Roxana Mehran September 23, 2018
Presentation TCT 2018 Utility of Cangrelor During PCI and Bridging Who Benefits Most? Presenter: John A. Bittl, C. Michael Gibson, Deepak L. Bhatt September 23, 2018
Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx November 01, 2017
Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes November 01, 2017
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice? Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy! Presenter: Stefan K. James, Ran Kornowski, Deepak L. Bhatt October 31, 2017
Presentation TCT 2016 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) and TROFI II 2-year Results Presenter: Deepak L. Bhatt, Stefan K. James, Manel Sabate October 31, 2016
Presentation TCT 2016 Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices? Presenter: Deepak L. Bhatt, Stefan K. James, Tullio Palmerini October 31, 2016
Presentation TCT 2016 Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI? Presenter: Deepak L. Bhatt, Stefan K. James, C. Michael Gibson October 31, 2016
Presentation TCT 2016 Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention for STEMI Improves Survival and Should Be Standard Practice! Presenter: Deepak L. Bhatt, Stefan K. James, Michael A. Kutcher October 31, 2016
Presentation TCT 2016 New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL Angiographic Core Lab Presenter: Deepak L. Bhatt, Stefan K. James, Christopher Overgaard October 31, 2016
Presentation TCT 2016 Aspiration Thrombectomy in STEMI: Data Synthesis, and How to Identify Patients Who Might Benefit Presenter: Deepak L. Bhatt, Stefan K. James, Eric A. Cohen October 31, 2016
Presentation TCT 2016 Pragmatic Simple Trials and Big Data: Implications for NIH Funding Presenter: Deepak L. Bhatt, Roxana Mehran, Michael S. Lauer October 31, 2016
Presentation TCT 2016 Pragmatic Simple Trials and Big Data: Advantages and Caveats Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington October 31, 2016
Presentation TCT 2016 Debate: Making the Case for Very Limited Use of Cangrelor! Presenter: Deepak L. Bhatt, Christian W. Hamm, Sorin J. Brener October 30, 2016
Presentation TCT 2016 Debate: Making the Case for Cangrelor Use in All PCI Patients! Presenter: Deepak L. Bhatt, Christian W. Hamm, Franz-Josef Neumann October 30, 2016